Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharm Res ; 27(6): 1066-71, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20112129

RESUMO

PURPOSE: To compare the chemopreventive efficacy of Polyphenon E (Poly E), (-)-epigallocatechin-3-gallate (EGCG) and Polyphenon E without EGCG (Poly E-EGCG) on the development of benzo(a)pyrene (B(a)P)-induced lung tumors in A/J mice. METHODS: Female A/J mice were given a single intraperitoneal injection of B(a)P (100 mg/kg body weight). One week after B(a)P injection, animals received AIN-76A purified powder diet containing 0.975% (wt/wt) EGCG, 0.525% (wt/wt) Poly E-EGCG or 1.5% (wt/wt) Poly E for 24 weeks or control diet with no additives. RESULTS: Poly E treatment significantly decreased tumor multiplicity by 52% and tumor load by 64%, while EGCG and Poly E-EGCG did not significantly inhibit lung tumor multiplicity. EGCG was more stable in a complex mixture (Poly E) than as a pure compound. CONCLUSION: EGCG was ineffective when administered by diet likely due to its instability. Thus, EGCG's efficacy on mice lung tumorigenesis requires the presence of other tea catechins.


Assuntos
Anticarcinógenos/uso terapêutico , Catequina/análogos & derivados , Neoplasias Pulmonares/prevenção & controle , Pulmão/efeitos dos fármacos , Animais , Catequina/administração & dosagem , Catequina/uso terapêutico , Quimioprevenção , Feminino , Pulmão/patologia , Neoplasias Pulmonares/dietoterapia , Neoplasias Pulmonares/patologia , Camundongos
2.
Cancer Prev Res (Phila) ; 2(6): 531-7, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19470785

RESUMO

Green tea has been shown to exhibit cancer-preventive activities in preclinical studies. However, (-)-epigallocatechin-3-gallate (EGCG) alone was shown to be ineffective in preventing lung tumorigenesis in mice by aerosol administration. In this study, Polyphenon E and Polyphenon E without EGCG were administered by aerosol delivery to A/J mice 2 weeks after carcinogen treatment and continuing daily throughout the remainder of the study (20 weeks). An improved aerosol delivery system with a custom-built atomizer, an efficient solvent remove system, and a nose-only exposure chamber was used to provide aerosols with stable size distribution. There were no significant differences in the size distributions of Polyphenon E and Polyphenon E without EGCG. With a relatively low dose level (4.19 mg/kg), Polyphenon E decreased tumor multiplicity by 53%, whereas Polyphenon E without EGCG at the same dose failed to inhibit lung carcinogenesis. These results indicate that aerosol administration can be an effective approach in chemoprevention study, and aerosolized Polyphenon E can significantly inhibit pulmonary adenoma formation and growth in A/J mice. Furthermore, in aerosolized form, EGCG, which is thought to be the most active component of Polyphenon E, has to be present with other tea catechins to show chemopreventive activity on lung tumorigenesis.


Assuntos
Adenoma/prevenção & controle , Anticarcinógenos/uso terapêutico , Catequina/análogos & derivados , Neoplasias Pulmonares/prevenção & controle , Chá/química , Adenoma/induzido quimicamente , Aerossóis , Animais , Anticarcinógenos/farmacologia , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Benzo(a)pireno/toxicidade , Disponibilidade Biológica , Catequina/administração & dosagem , Catequina/química , Catequina/farmacologia , Catequina/uso terapêutico , Ensaios de Seleção de Medicamentos Antitumorais , Sinergismo Farmacológico , Feminino , Neoplasias Pulmonares/induzido quimicamente , Camundongos , Camundongos Endogâmicos A
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...